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Supplementary Method 
 
Construction of the Genetic Risk Score and Mendelian randomization analysis 
We constructed a genetic risk score (GRS) for each individual based on the number of risk 
alleles of both ALDH2 rs671 and ADH1B rs1229984, previously related to alcohol flushing, 
which allowed us to achieve higher power in Mendelian randomization (MR) analyses. The 
extracted SNP data are described in Supplementary Table 4. We used the generated GRS as the 
instrumental variable in MR analyses to assess the causal role of alcohol intake on the 
hypertensive outcomes, using the same statistical methods as for main analyses.
Supplementary Figure legend 
 
Supplementary Figure 1. Distribution of genetic risk score in the study sample. The 
frequencies of genetic risk score (GRS) were approximately within normal distribution. The 
means of GRS were 2.17 ± 0.77 in the alcohol flusher group and 1.56 ± 0.67 in the alcohol 
non-flusher group, respectively. 
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0
200
400
600
800
1000
1200
1400
0 1 2 3 4
F
re
q
u
en
cy
 (
N
)
Genetic risk score
Supplementary Table 1. Characteristics of study participants according to rs671 genotype and gender. 
 Total1 
 
Men1  Women1 
Variables 
GG 
(n=1,505) 
GA+AA 
(n=506)1 
Beta coefficient; 
OR (95% CI) 2 
 GG 
(n=982) 
GA+AA 
(n=371) 
Beta coefficient; 
OR (95% CI) 2 
 
GG 
(n=523) 
GA+AA 
(n=135) 
Beta coefficient; 
OR (95% CI) 2 
Age (years) 56.0 ± 7.0 56.1 ± 7.3 0.078 (-0.636, 0.792)  56.1 ± 7.0 56.6 ± 7.5 0.509 (-0.344, 1.362)  55.7 ± 7.1 54.5 ± 6.3 -1.212 (-2.529, 0.104) 
BMI (kg/m2) 24.7 ± 2.8 24.5 ± 2.7 -0.232 (-0.511, 0.047)  24.7 ± 2.7 24.6 ± 2.7 -0.093 (-0.414, 0.228)  24.7 ± 3.0 24.1 ± 2.6 -0.610 (-1.168, -0.052) 
Monthly household income (n, %)            
<1,000 USD 172 (11.4) 47 (9.3) 1.000 (ref)  91 (9.3) 33 (8.9) 1.000 (ref)  81 (15.5) 14 (10.4) 1.000 (ref) 
1,000-2,000 USD 217 (14.4) 93 (18.4) 1.337 (1.023, 1.746)  126 (12.8) 61 (16.4) 1.337 (0.959, 1.864)  91 (17.4) 32 (23.7) 1.475 (0.934, 2.328) 
2,000–4,000 USD 615 (40.9) 202 (39.9) 0.962 (0.783, 1.181)  397 (40.4) 152 (41.0) 1.023 (0.802, 1.304)  218 (41.7) 50 (37.0) 0.823 (0.557, 1.216) 
≥6,000 USD  514 (33.3) 164 (32.4) 0.961 (0.775, 1.191)  368 (37.5) 125 (33.7) 0.848 (0.660, 1.090)  133 (25.4) 39 (28.9) 1.191 (0.782, 1.815) 
Drinking             
  Ex-drinker (n, %) 394 (26.2) 221 (43.7) 1.000 (ref)  160 (16.3) 143 (38.5) 1.000 (ref)  234 (44.7) 78 (57.8) 1.000 (ref) 
  Current drinker (n, %) 1,111 (73.8) 285 (56.3) 0.457 (0.371, 0.564)  822 (83.7) 228 (61.5) 0.310 (0.237, 0.406)  289 (55.3) 57 (42.2) 0.592 (0.404, 0.867) 
  Total alcohol intake (g/day) 15.1 ± 23.8 7.2 ± 17.5 -7.943 (-10.195, -5.692)  21.3 ± 26.8 9.2 ± 19.9 -12.098 (-15.100, -9.096)  3.5 ± 8.2 1.6 ± 4.1 -1.911 (-3.336, -0.486) 
  Alcohol flushing (n, %) 281 (18.7) 400 (79.1) -  174 (17.7) 296 (79.8) -  107 (20.5) 104 (77.0) - 
Smoking (n, %)            
Non-smoker  684 (45.5) 209 (41.3) 1.000 (ref)  183 (18.6) 76 (20.5) 1.000 (ref)  501 (95.8) 133 (98.5) 1.000 (ref) 
Ex-smoker 520 (34.6) 195 (27.3) 1.188 (0.964, 1.463)  513 (52.2) 194 (52.3) 1.002 (0.789, 1.273)  7 (1.3) 1 (0.7) 0.550 (0.067, 4.510) 
Current-smoker 301 (20.0) 102 (20.2) 1.010 (0.786, 1.298)  286 (29.1) 101 (27.2) 0.910 (0.697, 1.189)  15 (2.9) 1 (0.7) 0.253 (0.033, 1.930) 
Physical activity 950 (63.1) 339 (67.0) 1.186 (0.959, 1.467)  617 (62.8) 250 (67.4) 1.222 (0.949, 1.574)  333 (63.7) 89 (65.9) 1.104 (0.741, 1.644) 
  MET-hours (hour/day) 42.3 ± 6.3 42.5 ± 7.0 0.265 (-0.388, 0.917)  42.6 ± 6.7 42.9 ± 7.5 0.316 (-0.516, 1.149)  41.7 ± 5.3 41.6 ± 5.3 -0.139 (-1.142, 0.863) 
Adult height (cm) 163.3 ± 8.1 164.0 ± 7.6 0.742 (-0.060, 1.544)  167.6 ± 5.5 167.2 ± 5.6 -0.483 (-1.145, 0.180)  155.1 ± 5.2 155.4 ± 5.4 0.300 (-0.694, 1.294) 
Medication use            
  Anti-diabetic medications 168 (11.2) 43 (8.5) 0.739 (0.520, 1.050)  127 (12.9) 39 (10.5) 0.791 (0.541, 1.157)  41 (7.8) 4 (3.0) 0.359 (0.126, 1.020) 
  Anti-hypertensive medications 418 (27.8) 116 (22.9) 0.773 (0.611, 0.979)  281 (28.6) 91 (24.5) 0.811 (0.616, 1.066)  137 (26.2) 25 (18.5) 0.640 (0.398, 1.031) 
  Anti-dyslipidemic medications 82 (5.5) 31 (6.1) 1.133 (0.740, 1.734)  42 (4.3) 19 (5.1) 1.208 (0.693, 2.106)  40 (7.7) 12 (8.9) 1.178 (0.600, 2.313) 
OR, Odds ratio; CI, confidence interval; USD, US dollars; MET, metabolic equivalent.  
1 Values are means ± SD for continuous variables, or number (percentages) for categorical variables.  
2 Values were derived by logistic regression for the categorical variables (Odds ratio [95% Confidence Intervals]) or by linear regression for the continuous variables (beta 
coefficient [95% Confidence Intervals]) and represent the change in each variable by the rs671 genotype status (GA+AA vs. GG).  
  
Supplementary Table 2. Association of rs671 genotype with flushing among Korean men and women. 
Ever drinkers 
Total (n=2,011)  Men (n=1,112)  Women (n=535) 
N OR (95% CI) P-value  N OR (95% CI) P-value  N OR (95% CI) P-value 
ALDH2 rs671            
  GG  1,505 1.00 (ref)   982 1.00 (ref)   523 1.00 (ref)  
 GA 487 16.9 (13.04, 21.90) <1.0×10-18  356 18.70 (13.68, 25.56) <1.0×10-18  131 13.23 (8.29, 21.11) <1.0×10-18 
 AA 19 41.28 (9.42, 180.98) 8.1×10-7  15 73.39 (9.51, 566.57) 3.8×10-5  4 13.63 (1.38, 134.98) 0.026 
Dominant model (GG vs GA+AA) 2,011 17.35 (13.42, 22.44) <1.0×10-18  1,112 19.41 (14.23, 26.48) <1.0×10-18  535 13.24 (8.35, 21.01) <1.0×10-18 
Recessive model (GG+GA vs AA) 2,011 17.96 (4.12, 78.30) 0.0001  1,112 29.40 (3.83, 225.53) 0.001  535 7.69 (0.78, 75.43) 0.080 
Additive model 2,011 16.10 (12.48, 20.77) <1.0×10-18  1,112 18.10 (13.30, 24.64) <1.0×10-18  535 12.13 (7.69, 19.12) <1.0×10-18 
OR, Odds ratio; CI, confidence interval 
1ORs were obtained by logistic regression using rs671 genotype as an exposure. The reference genotype in the additive model was GG. All regression models were adjusted 
for age, sex (for total subjects), income, MET-hour/day and smoking status and represent the odds of being an alcohol flusher (vs. non-flusher) with each genotype and model 
of the rs671 genetic variant. 
  
Supplementary Table 3. Instrumental variable estimates of alcohol intake (g/day) and hypertension based on alcohol flushing including those categorized as 
“never-drinkers-but-flushers”. 
 
 
Total 
(n=2,595) 
 
Men 
(n=1,468) 
 Women 
(n=1,127) 
   
Diseases OR (95% CI)1 P-value2  OR (95% CI) P-value2  OR (95% CI) P-value2 
   Hypertension 1.023 (1.001, 1.045) 0.040  1.022 (1.005, 1.040) 0.012  0.994 (0.841, 1.174) 0.941 
Blood pressure  
Beta coefficient 
(95% CI) 
P-value  
Beta coefficient 
(95% CI) 
P-value  
Beta coefficient 
(95% CI) 
P-value 
   SBP (mmHg) 0.117 (-0.022, 0.256) 0.099  0.052 (-0.059, 0.164) 0.359  0.694 (-0.372, 1.760) 0.202 
    Adjusting treatment effect +10mmHg3 0.151 (0.001, 0.302) 0.048  0.088 (-0.032, 0.208) 0.149  0.690 (-0.462, 1.842) 0.241 
    Adjusting treatment effect +15mmHg3 0.169 (0.009, 0.328) 0.039  0.106 (-0.021, 0.234) 0.102  0.688 (-0.530, 1.906) 0.268 
   DBP (mmHg) 0.116 (0.028, 0.204) 0.010  0.073 (0.001, 0.146) 0.046  0.459 (-0.181, 1.098) 0.160 
    Adjusting treatment effect +5mmHg3 0.133 (0.041, 0.225) 0.005  0.091 (0.016, 0.167) 0.017  0.457 (-0.216, 1.129) 0.183 
    Adjusting treatment effect +10mmHg3 0.151 (0.050, 0.251) 0.003  0.110 (0.028, 0.191) 0.009  0.455 (-0.278, 1.188) 0.224 
OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure 
1 ORs and beta coefficients by instrumental variable (IV) estimation were obtained from IV regressions with a two-stage least squares estimation method (in logistic and linear 
regression models, respectively), using alcohol flushing as an instrument for alcohol intake. To predict the amount of alcohol intake, non-flushers were regarded as a reference 
group.  
2 P values were derived from IV regression analysis with adjustment for age, sex (for total subjects), income, MET-hour/day and smoking status.  
3 To adjust treatment effect on blood pressure, sensible constants were added to the observed blood pressure values of all subjects on treatment (see Methods).
Supplementary Table 4. Association of genetic risk score with characteristics of study participants according to gender. 
 
SD, Standard deviation; OR, Odds ratio; CI, Confidence intervals; USD, US dollars; MET, metabolic equivalent.  
1 The unweighted genetic risk score was constructed by summation of the number of risk alleles in ALDH2 rs671 (G allele) an ADH1B in rs1229984 (C allele).  
2 Values are percentages (%) for categorical variables (e.g. ALDH2 rs671 and ADH1B rs1229984), or means ± SD for continuous variables (e.g. genetic risk score). 
3 Values were derived by logistic regression for the categorical variables (Odds ratio [95% Confidence Interval]) or by linear regression for the continuous variables (beta 
coefficient [95% Confidence Intervals]) and represent the change in each variable by increase of genetic risk score.  
 Total 
(n=2,011) 
 Men 
(n=1,353) 
 Women 
(n=658)    
Genotypes Percentage or mean 2  Percentage or mean  Percentage or mean 
rs671 in ALDH2 (GG / AG+AA, %) 74.8 / 25.2   72.6 / 27.4   79.5 / 20.5  
rs1229984 in ADH1B (TT+TC / CC, %) 94.0 / 6.0   93.9 / 6.1   94.2 / 5.8  
Genetic risk score (mean ± SD)1 2.23 ± 0.77   2.19 ± 0.77   2.31 ± 0.74  
Variables 
OR / Beta coefficient 
(95% CI) 3 
P-value  
OR / Beta coefficient 
(95% CI) 
P-value  
OR / Beta coefficient 
(95% CI) 
P-value 
Age (years) 0.066 (-0.339, 0.471) 0.751  0.002 (-0.490, 0.494) 0.994  0.315 (-0.405, 1.034) 0.390 
Monthly household income (n, %)         
  <1,000 USD 1.000 (ref) -       
  1,000-2,000 USD 0.920 (0.785, 1.078) 0.301  0.928 (0.760, 1.133) 0.463  0.862 (0.661, 1.124) 0.272 
  2,000–4,000 USD 0.999 (0.889, 1.122) 0.985  1.014 (0.881, 1.166) 0.848  0.965 (0.782, 1.191) 0.741 
  ≥6,000 USD 1.031 (0.913, 1.164) 0.625  1.014 (0.879, 1.169) 0.853  1.166 (0.921, 1.476) 0.201 
Drinking         
  Ex-drinker  1.000 (ref) -       
  Current-drinker 1.256 (1.108, 1.424) 0.0004  1.585 (1.333, 1.884) 1.8 x ×10-7  1.078 (0.876, 1.325) 0.478 
  Total alcohol intake (g/day) 2.828 (1.542, 4.114) 0.00002  4.690 (2.939, 6.441) 1.7 x ×10-7  0.813 (0.034, 1.591) 0.041 
Smoking (n, %)         
  Non-smoker 1.000 (ref) -       
  Ex-smoker 0.899 (0.798, 1.013) 0.081  0.986 (0.859, 1.131) 0.838  1.128 (0.440, 2.892) 0.803 
  Current-smoker 0.936 (0.812, 1.080) 0.367  1.006 (0.864, 1.172) 0.934  1.005 (0.514, 1.963) 0.989 
Physical activity 0.947 (0.841, 1.067) 0.372  0.948 (0.822, 1.095) 0.469  0.943 (0.761, 1.170) 0.596 
MET-hours (hour/day) -0.502 (-0.873, -0.132) 0.008  -0.492 (-0.972, -0.011) 0.045  -0.392 (-0.938, 0.154) 0.159 
Adult height (cm) -0.731 (-1.185, -0.277) 0.002  -0.242 (-0.624, 0.140) 0.213  -0.073 (-0.615, 0.469) 0.792 
Medication use         
   Anti-diabetic medications 1.076 (0.893, 1.296) 0.441  1.132 (0.918, 1.395) 0.246  1.002 (0.666, 1.508) 0.992 
   Anti-hypertensive medications 1.087 (0.956, 1.237) 0.204  1.131 (0.970, 1.320) 0.117  1.012 (0.796, 1.285) 0.925 
   Anti-dyslipidemic medications 0.891 (0.695, 1.143) 0.363  0.896 (0.642, 1.251) 0.519  0.823 (0.561, 1.207) 0.318 
Supplementary Table 5. Instrumental variable estimates of alcohol intake (g/day) and hypertension based on genetic risk score1 for alcohol flushing. 
 
 
Total 
(n=2,011) 
 
Men 
(n=1,468) 
 Women 
(n=1,127) 
   
Diseases OR (95% CI)2 P-value3  OR (95% CI) P-value3  OR (95% CI) P-value3 
   Hypertension 1.035 (0.999, 1.072) 0.058  1.034 (1.002, 1.066) 0.012  1.024 (0.793, 1.322) 0.857 
Blood pressure  
Beta coefficient 
(95% CI) 
P-value  
Beta coefficient 
(95% CI) 
P-value  
Beta coefficient 
(95% CI) 
P-value 
   SBP (mmHg) 0.406 (0.146, 0.665) 0.002  0.386 (0.152, 0.620) 0.001  0.547 (-1.129, 2.224) 0.522 
    Adjusting treatment effect +10mmHg4 0.446 (0.165, 0.726) 0.002  0.435 (0.181, 0.689) 0.001  0.491 (-1.325, 2.307) 0.596 
    Adjusting treatment effect +15mmHg4 0.465 (0.169, 0.762) 0.002  0.459 (0.190, 0.729) 0.001  0.463 (-1.457, 2.383) 0.636 
   DBP (mmHg) 0.196 (0.042, 0.350) 0.013  0.166 (0.028, 0.304) 0.019  0.448 (-0.552, 1.447) 0.380 
    Adjusting treatment effect +5mmHg4 0.216 (0.054, 0.378) 0.009  0.190 (0.046, 0.335) 0.010  0.419 (-0.631, 1.470) 0.434 
    Adjusting treatment effect +10mmHg4 0.236 (0.059, 0.412) 0.009  0.215 (0.057, 0.373) 0.008  0.391 (-0.752, 1.534) 0.502 
OR, odds ratio; CI, confidence interval; SBP, systolic blood pressure; DBP, diastolic blood pressure 
1 The unweighted genetic risk score was constructed by summation of the number of risk alleles in ALDH2 rs671 (G allele) an ADH1B in rs1229984 (C allele). 
2 ORs and beta coefficients by instrumental variable (IV) estimation were obtained from IV regressions with a two-stage least squares estimation method (in logistic and linear 
regression models, respectively), using genetic risk score for alcohol flushing as an instrument for alcohol intake. To predict the amount of alcohol intake, 0 for genetic risk 
score was regarded as a reference value.  
3 P values were derived from IV regression analysis with adjustment for age, sex (for total subjects), income, MET-hour/day and smoking status.  
4 To adjust treatment effect on blood pressure, sensible constants were added to the observed blood pressure values of all subjects on treatment (see Methods). 
  
Supplementary Table 6. A comparison of alcohol intake between those who were homozygous for the G allele of the rs671 SNP with and without flushing . 
 
 
Total 
(n=1,505) 
 
Men 
(n=1,468) 
 Women 
(n=1,127) 
   
Alcohol intake (g/day) N 
Beta coefficient 
(95% CI) 1 
P-
value1 
 N 
Beta coefficient 
(95% CI) 1 
P-
value1 
 N 
Beta coefficient 
(95% CI) 1 
P-
value1 
 rs671 GG genotype without flushing symptom 1,224 1.000 (ref) -  808 1.000 (ref) -  416 1.000 (ref) - 
 rs671 GG genotype with flushing symptom 281 -6.840 (-9.904, 3.776) 1.3×10-5  174 -8.668 (-13.036, -4.300) 1.1×10-4  107 -1.830 (-3.564, -0.095) 0.039 
 
CI, confidence interval. 
1Beta coefficient and P-values were obtained from linear regression using a combination of rs671 genotype and flushing as an exposure.  
  
Supplementary Table 7. Distribution of genotypes of the ALDH2 rs671 and ADH1B rs1229984 SNPs 
according to flushing status. 
 
 
Non-flusher  
(n=1,330) 
 Flusher 
(n=681) 
rs1229984 
rs6711  rs6711 
GG GA AA  GG GA AA 
  TT 668 (54.6) 56 (53.9) 0 (0.0)  179 (63.7) 226 (59.0) 11 (64.7) 
  TC 477 (39.0) 40 (38.5) 2 (0.4)  93 (33.1) 134 (35.0) 5 (29.4) 
  CC 79 (6.5) 8 (7.7) 0 (0.0)  9 (3.2) 23 (6.0) 21 (5.9) 
 
1 Values are number of the participants and percentages (%). 
